Correspondence to letter to the editor on "Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis".
作者信息
Kim Hee Yeon, Choi Miyoung, Jun Dae Won
机构信息
Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea.
Division of Health Technology Assessment Research, National Evidence-Based Healthcare Collaborating Agency (NECA), Seoul, Korea.
出版信息
Clin Mol Hepatol. 2025 Jan;31(1):e105-e107. doi: 10.3350/cmh.2024.0937. Epub 2024 Nov 4.
Abstract
摘要
相似文献
1
Correspondence to letter to the editor on "Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis".致编辑的信，主题为“普通人群中具有临床意义的肝纤维化患病率：一项系统评价和荟萃分析”。
Clin Mol Hepatol. 2025 Jan;31(1):e105-e107. doi: 10.3350/cmh.2024.0937. Epub 2024 Nov 4.
2
Correspondence to editorial on "Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis".致关于“普通人群中具有临床意义的肝纤维化患病率：一项系统评价和荟萃分析”的社论的信函。
Clin Mol Hepatol. 2025 Jan;31(1):e48-e51. doi: 10.3350/cmh.2024.0777. Epub 2024 Sep 11.
3
Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis.一般人群中临床显著肝纤维化的患病率：系统评价和荟萃分析。
Clin Mol Hepatol. 2024 Sep;30(Suppl):S199-S213. doi: 10.3350/cmh.2024.0351. Epub 2024 Jul 30.
4
Spotting undiagnosed significant liver fibrosis in the general population: impact on subsequent clinical care: Editorial on "Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis".在普通人群中发现未诊断出的显著肝纤维化：对后续临床护理的影响：关于“普通人群中临床显著肝纤维化的患病率：系统评价和荟萃分析”的社论
Clin Mol Hepatol. 2025 Jan;31(1):256-260. doi: 10.3350/cmh.2024.0737. Epub 2024 Sep 3.
5
Age serves as the silent architect of FIB-4's precision in unveiling advanced hepatic fibrosis in MASLD with T2DM: Correspondence to letter to the editor on "Diagnostic accuracy of the fibrosis-4 index for advanced liver fibrosis in nonalcoholic fatty liver disease with type 2 diabetes: a systematic review and meta-analysis".年龄是FIB-4在揭示合并2型糖尿病的代谢相关脂肪性肝病（MASLD）中晚期肝纤维化时精准度的无声塑造者：致编辑的信，主题为“2型糖尿病非酒精性脂肪性肝病中纤维化-4指数对晚期肝纤维化的诊断准确性：一项系统评价和荟萃分析”
Clin Mol Hepatol. 2025 Apr;31(2):e152-e154. doi: 10.3350/cmh.2024.1160. Epub 2024 Dec 30.
6
Letter regarding "Prevalence of clinically significant liver fibrosis in the general population".关于“普通人群中具有临床意义的肝纤维化患病率”的信函
Clin Mol Hepatol. 2025 Jan;31(1):e21-e22. doi: 10.3350/cmh.2024.0887. Epub 2024 Oct 11.
7
Letter to the Editor: Imaging-based noninvasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline.致编辑的信：基于影像学的慢性肝病肝纤维化分期无创性肝病评估：支持美国肝病研究学会实践指南的系统评价
Hepatology. 2025 Feb 1;81(2):E28-E29. doi: 10.1097/HEP.0000000000000951. Epub 2024 Jun 24.
8
Global Prevalence of Advanced Liver Fibrosis and Cirrhosis in the General Population: A Systematic Review and Meta-analysis.普通人群中晚期肝纤维化和肝硬化的全球患病率：一项系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2025 Jun;23(7):1123-1134. doi: 10.1016/j.cgh.2024.08.020. Epub 2024 Aug 30.
9
The prevalence of nonalcoholic fatty liver disease in people living with HIV: a systematic review and meta-analysis.艾滋病毒感染者中非酒精性脂肪性肝病的患病率：一项系统评价和荟萃分析。
BMC Infect Dis. 2025 Feb 19;25(1):239. doi: 10.1186/s12879-025-10455-y.
10
Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review.一般人群中用非侵入性肝纤维化标志物定义的临床显著肝脏疾病的流行情况：系统评价。
Lancet Gastroenterol Hepatol. 2017 Apr;2(4):288-297. doi: 10.1016/S2468-1253(16)30205-9. Epub 2017 Feb 1.
本文引用的文献
1
Letter regarding "Prevalence of clinically significant liver fibrosis in the general population".关于“普通人群中具有临床意义的肝纤维化患病率”的信函
Clin Mol Hepatol. 2025 Jan;31(1):e21-e22. doi: 10.3350/cmh.2024.0887. Epub 2024 Oct 11.
2
Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis.一般人群中临床显著肝纤维化的患病率：系统评价和荟萃分析。
Clin Mol Hepatol. 2024 Sep;30(Suppl):S199-S213. doi: 10.3350/cmh.2024.0351. Epub 2024 Jul 30.
3
Association of liver fibrosis with cognitive test performance and brain imaging parameters in the UK Biobank study.英国生物库研究中肝纤维化与认知测试表现和脑影像参数的相关性。
Alzheimers Dement. 2023 Apr;19(4):1518-1528. doi: 10.1002/alz.12795. Epub 2022 Sep 23.
4
Prevalence of High Liver Stiffness and a Screening Strategy Using the SODA-2B Score Among US Adults.美国成年人中高肝脏硬度的流行率和使用 SODA-2B 评分的筛查策略。
Hepatol Commun. 2022 Apr;6(4):898-909. doi: 10.1002/hep4.1837. Epub 2021 Oct 25.
5
Liver function tests and fibrosis scores in a rural population in Africa: a cross-sectional study to estimate the burden of disease and associated risk factors.在非洲农村人群中进行的肝功能试验和纤维化评分：一项横断面研究，旨在估计疾病负担和相关危险因素。
BMJ Open. 2020 Mar 31;10(3):e032890. doi: 10.1136/bmjopen-2019-032890.
6
High Prevalence of Hepatic Fibrosis, Measured by Elastography, in a Population-Based Study of Mexican Americans.基于人群的墨西哥裔美国人研究中，通过弹性成像技术测量的肝纤维化患病率较高。
Clin Gastroenterol Hepatol. 2019 Apr;17(5):968-975.e5. doi: 10.1016/j.cgh.2018.05.046. Epub 2018 Jun 11.
Zotero 插件